Senate Kills Amendment To Drop "First-To-File" Patent Process From Reform Legislation
This article was originally published in The Pink Sheet Daily
Executive Summary
Sponsors prevail in effort to align U.S. system with those of other industrialized countries, who all follow first-to-file procedures.
You may also be interested in...
Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory
With the Senate poised to approve its version of the patent reform bill, House Judiciary Committee Chairman Lamar Smith, R-Texas, will soon be in the driver's seat of a piece of legislation that could significantly alter the relationships pharmaceutical companies have with both their licensing partners and generic adversaries.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.